Dr. Chong-Chou Lee/李宗洲博士
Education
- Ph.D., University of Texas Health Science Center at San Antonio, Texas, USA (1990)
- M.Sc., Department of Biology, Tunghai University, Taiwan (1990)
- B.S., Department of Biology, Tunghai University, Taiwan (1980
Professional Experiences
- President, AcadeMab Biomedical Inc. (2023/03-present)
- Research Specialist, Biomedical Translation Research Center, Academia Sinica (2021-2023)
- Executive Director, BioMed Commercialization Center (2020-2020)
- President, A-Spine Asia Co., Ltd. (2017-2019)
- CEO, Spirit Spine Co., Ltd. (2015-2017)
- President, Medigen Vaccinology Corp. (2014-2015)
- Director of Biotechnology Unit, Board of Science and Technology, Executive Yuan (Cabinet) (2005-2014)
- Research Fellow, Industrial Technology Research Institute (2004-2014)
- Senior Scientist/ Associate Director, R&D, Vita Genomics, Inc. (2001-2003)
- Research Scientist, Van Andel Research Institute, Grand Rapids, USA (1999-2001)
- Postdoctoral Fellow/ Research Fellow, National Institutes of Health, Bethesda, USA (1990-1999)
